December 7, 2023 Comments Off on New patent expiration for Boehringer Ingelheim drug STIOLTO RESPIMAT Posted in: Uncategorized
Annual Drug Patent Expirations for STIOLTO+RESPIMAT Stiolto Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Boehringer Ingelheim d…
December 7, 2023 Comments Off on New patent expiration for Boehringer Ingelheim drug STRIVERDI RESPIMAT Posted in: Uncategorized
Annual Drug Patent Expirations for STRIVERDI+RESPIMAT Striverdi Respimat is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent expiration for Boehringer Ingelhe…
